[144] Trane Technologies plc SEC Filing

Rhea-AI Filing Summary

Trane Technologies plc (TT) reported a Form 144 notice for a proposed sale of 22,497 common shares, with an aggregate market value of $9,223,770.00. The shares represent approximately 0.01% of the 222,515,359 shares outstanding and the sale is planned on 09/02/2025 on the NYSE through UBS Financial Services, Inc.

The filer indicates the shares were acquired on 09/02/2025 by exercise of a stock option from the issuer and paid in cash. The filing reports no other sales in the past three months and includes the signers representation about lack of undisclosed material adverse information.

Positive

• Clear disclosure of the number of shares (22,497), aggregate value ($9,223,770.00), and sale date (09/02/2025)
• Acquisition method specified: shares were acquired by exercise of a stock option and paid in cash on 09/02/2025
• Transaction size is immaterial relative to outstanding shares (~0.01%), reducing likelihood of market impact
• Broker identified as UBS Financial Services, indicating use of an established brokerage for the sale

Negative

• None.

Insights

Securities Analyst

TL;DR: Insider exercised options and filed to sell 22,497 shares worth $9.22M, a very small portion of outstanding stock.

The filing documents an exercise-and-sale transaction: acquisition and intended sale occurred on the same date, indicating immediate liquidity of newly exercised shares. The position size is approximately 0.01% of outstanding shares, so the transaction is unlikely to move the market by itself. The use of a major broker (UBS Financial Services) and the Form 144 compliance suggests standard insider reporting and planning for an orderly sale under Rule 144.

Corporate Governance Expert

TL;DR: Procedural disclosure aligns with Rule 144 requirements; signer attests no undisclosed material adverse information.

The notice includes the statutory attestation about material nonpublic information and notes no sales in the past three months. From a governance perspective, timely Form 144 filing and clear identification of acquisition method (stock option exercise) conform to disclosure expectations for insider transactions. The document contains no indications of unusual trading arrangements or 10b5-1 plan details.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	22497	9223770.00	222515359	09/02/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/02/2025	Exercise of Stock Option	Issuer			22497	09/02/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did Trane Technologies (TT) disclose on this Form 144?

The filer disclosed a proposed sale of 22,497 common shares valued at $9,223,770.00, planned for 09/02/2025 on the NYSE through UBS Financial Services.

How and when were the shares acquired for the Form 144 sale?

The shares were acquired on 09/02/2025 by exercise of a stock option from the issuer, with payment in cash on the same date.

What percentage of outstanding shares does the proposed sale represent?

The proposed sale of 22,497 shares represents approximately 0.01% of the 222,515,359 shares outstanding reported in the filing.

Did the filing report other sales in the past three months?

No. The filing states "Nothing to Report" for securities sold during the past three months by the person for whose account the securities are to be sold.

Does the filing include any 10b5-1 plan adoption date?

No date for a plan adoption or instruction under Rule 10b5-1 is provided in the filing.